Share Price and Basic Stock Data
Last Updated: February 12, 2026, 10:29 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Organic Chemicals Ltd (HOCL) operates within the organic chemicals sector, focusing on benzene-based products. The company’s revenue trajectory has shown fluctuations in recent quarters, with sales recorded at ₹139 Cr in September 2022, rising to ₹194 Cr by March 2023. However, subsequent quarters saw a decline, with revenue dropping to ₹59 Cr in June 2024 before recovering to ₹175 Cr in September 2024. For the trailing twelve months (TTM), total sales stood at ₹592 Cr, indicating a year-on-year increase from ₹631 Cr in March 2023 to ₹704 Cr in March 2024. This volatility reflects both market challenges and operational adjustments as HOCL navigates the competitive landscape of the chemicals industry. The company’s operating profit margin (OPM) remained negative for most reporting periods, with a low of -40% in June 2024, suggesting ongoing cost pressures. Despite these challenges, HOCL has a substantial reserve of ₹953 Cr, which could provide a buffer for future investments and operational stability.
Profitability and Efficiency Metrics
HOCL’s profitability metrics reveal a challenging financial landscape. The company recorded a net profit of ₹416 Cr, yet this figure masks a history of losses, particularly in recent quarters where net profit was negative in several instances, including a significant loss of ₹79 Cr in December 2024. The operating profit has fluctuated, with a peak of ₹16 Cr in March 2023 but declining to -37 Cr by March 2025. The interest coverage ratio (ICR) stood at -1.48x, indicating that the company is currently unable to cover its interest expenses through its earnings, which raises concerns about financial sustainability. The return on equity (ROE) at 21.6% is a relative strength, reflecting efficient use of shareholder funds when compared to industry norms. However, the return on capital employed (ROCE) is low at 5.20%, indicating inefficiencies in utilizing capital for generating earnings. Overall, while HOCL has demonstrated some profitability, the persistent negative operating margins and declining net profits present significant challenges.
Balance Sheet Strength and Financial Ratios
HOCL’s balance sheet reveals a complex financial structure with total liabilities of ₹1,539 Cr against total assets of ₹1,568 Cr, indicating a relatively stable position. The company has reported borrowings of ₹232 Cr, significantly reduced from previous years, reflecting improved debt management strategies. The current ratio is a healthy 3.61x, suggesting strong liquidity and an ability to meet short-term obligations. However, the price-to-book value (P/BV) ratio is notably low at 0.27x, indicating that the market undervalues the company’s equity relative to its book value, which could be a concern for investors. Additionally, the cash conversion cycle (CCC) stood at 24 days, highlighting efficient inventory and receivables management. Despite these strengths, the negative operating profit margins and low ROCE raise red flags about operational efficiency and overall financial health, necessitating careful scrutiny by potential investors.
Shareholding Pattern and Investor Confidence
The shareholding structure of HOCL shows a strong promoter holding of 58.78%, which indicates substantial insider confidence in the company’s long-term prospects. However, foreign institutional investors (FIIs) are not present, and domestic institutional investors (DIIs) hold a mere 0.02%, suggesting limited institutional interest in the company. The public shareholding stood at 41.20%, with the number of shareholders rising to 61,587, reflecting growing retail investor participation. This could be a positive indicator of market sentiment, particularly as the company’s financial performance stabilizes. However, the lack of institutional backing may raise concerns regarding liquidity and the stock’s ability to attract larger investments. The low DII participation might also imply that institutional investors are cautious about the company’s operational challenges and profitability outlook, which could impact future stock performance and market confidence.
Outlook, Risks, and Final Insight
Looking ahead, HOCL faces a mixed outlook marked by both opportunities and risks. The company’s healthy reserves and strong promoter backing provide a solid foundation for potential recovery. However, persistent operational inefficiencies, as evidenced by negative operating margins and low ROCE, pose significant risks that could hinder growth. Additionally, the high debt levels relative to equity and negative interest coverage ratio raise concerns about financial stability. The chemical industry’s inherent volatility, combined with fluctuating demand dynamics, further complicates the outlook. If HOCL can stabilize its operational performance and enhance profitability, it may attract more institutional interest, improving its market valuation. Conversely, if operational challenges continue unabated, the company may struggle to leverage its existing strengths, leading to a decline in investor confidence and stock performance. Thus, stakeholders must remain vigilant regarding HOCL’s strategic initiatives and market positioning in the coming quarters.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 213 Cr. | 31.8 | 45.0/22.4 | 152 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 15,835 Cr. | 1,530 | 2,040/1,412 | 33.1 | 287 | 0.49 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 39.3 Cr. | 16.0 | 24.2/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 8,024.00 Cr | 525.93 | 33.10 | 249.33 | 0.16% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 174 | 194 | 145 | 189 | 187 | 183 | 59 | 175 | 165 | 137 | 164 | 126 |
| Expenses | 157 | 173 | 177 | 154 | 177 | 190 | 183 | 83 | 175 | 191 | 173 | 177 | 143 |
| Operating Profit | -17 | 1 | 16 | -9 | 11 | -3 | -1 | -24 | 0 | -26 | -37 | -13 | -17 |
| OPM % | -12% | 1% | 8% | -6% | 6% | -2% | -0% | -40% | 0% | -16% | -27% | -8% | -14% |
| Other Income | 9 | 3 | -5 | 3 | 5 | 4 | 7 | 5 | 5 | -35 | 551 | 13 | 5 |
| Interest | 13 | 17 | 17 | 17 | 17 | 18 | 17 | 16 | 18 | 18 | -10 | 5 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 523 | -6 | -18 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 0% | 0% |
| Net Profit | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 520 | -6 | -18 |
| EPS in Rs | -3.12 | -2.01 | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 | -0.94 | -2.70 |
Last Updated: January 6, 2026, 11:44 pm
Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 126.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Jun 2025) to 126.00 Cr., marking a decrease of 38.00 Cr..
- For Expenses, as of Sep 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 177.00 Cr. (Jun 2025) to 143.00 Cr., marking a decrease of 34.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -17.00 Cr.. The value appears to be declining and may need further review. It has decreased from -13.00 Cr. (Jun 2025) to -17.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Sep 2025, the value is -14.00%. The value appears to be declining and may need further review. It has decreased from -8.00% (Jun 2025) to -14.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 5.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Jun 2025) to -18.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Jun 2025) to -18.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.70. The value appears to be declining and may need further review. It has decreased from -0.94 (Jun 2025) to -2.70, marking a decrease of 1.76.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 592 |
| Expenses | 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 685 |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -93 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -16% |
| Other Income | 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 534 |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 19 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | 420 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | |
| Net Profit | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | 416 |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | 61.99 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.43% | 14.75% | -40.00% | 27.80% | 139.04% | -234.25% | 91.84% | -300.00% | -71.88% | 1.82% | 825.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.17% | -54.75% | 67.80% | 111.24% | -373.28% | 326.08% | -391.84% | 228.12% | 73.69% | 824.11% |
Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 | 953 |
| Borrowings | 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 | 232 |
| Other Liabilities | 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 | 286 |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
| Fixed Assets | 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | 230 |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 | 1,308 |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 67.00 Cr..
- For Reserves, as of Sep 2025, the value is 953.00 Cr.. The value appears to be declining and may need further review. It has decreased from 978.00 Cr. (Mar 2025) to 953.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 219.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 286.00 Cr.. The value appears to be improving (decreasing). It has decreased from 304.00 Cr. (Mar 2025) to 286.00 Cr., marking a decrease of 18.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,308.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,336.00 Cr. (Mar 2025) to 1,308.00 Cr., marking a decrease of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
Notably, the Reserves (953.00 Cr.) exceed the Borrowings (232.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -702.00 | -827.00 | -824.00 | -762.00 | -776.00 | -578.00 | -579.00 | -491.00 | 0.00 | 5.00 | -2.00 | -305.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 |
| Working Capital Days | -534 | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Diluted EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Cash EPS (Rs.) | 58.51 | -7.83 | -8.05 | -4.19 | -0.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Revenue From Operations / Share (Rs.) | 79.66 | 104.64 | 93.87 | 64.47 | 61.70 |
| PBDIT / Share (Rs.) | -9.42 | 2.33 | 1.90 | 3.45 | 7.10 |
| PBIT / Share (Rs.) | -9.67 | 2.12 | 1.72 | 3.28 | 6.67 |
| PBT / Share (Rs.) | 58.70 | -8.22 | -8.23 | -4.37 | -1.30 |
| Net Profit / Share (Rs.) | 58.27 | -8.04 | -8.23 | -4.37 | -1.30 |
| NP After MI And SOA / Share (Rs.) | 58.24 | -8.12 | -7.89 | -3.97 | -1.61 |
| PBDIT Margin (%) | -11.82 | 2.22 | 2.02 | 5.35 | 11.50 |
| PBIT Margin (%) | -12.13 | 2.02 | 1.83 | 5.08 | 10.80 |
| PBT Margin (%) | 73.68 | -7.85 | -8.76 | -6.77 | -2.11 |
| Net Profit Margin (%) | 73.14 | -7.68 | -8.76 | -6.77 | -2.11 |
| NP After MI And SOA Margin (%) | 73.11 | -7.76 | -8.41 | -6.15 | -2.60 |
| Return on Networth / Equity (%) | 37.47 | 0.00 | 0.00 | 0.00 | -34.97 |
| Return on Capital Employeed (%) | -5.43 | 14.22 | 11.03 | 13.99 | 16.73 |
| Return On Assets (%) | 25.04 | -3.47 | -3.56 | -1.81 | -0.75 |
| Long Term Debt / Equity (X) | 0.00 | -0.04 | 0.00 | 0.00 | 2.49 |
| Total Debt / Equity (X) | 0.19 | -16.20 | -16.51 | -197.52 | 13.60 |
| Asset Turnover Ratio (%) | 0.34 | 0.45 | 0.42 | 0.29 | 0.29 |
| Current Ratio (X) | 3.61 | 0.91 | 0.95 | 0.99 | 1.11 |
| Quick Ratio (X) | 3.46 | 0.86 | 0.91 | 0.94 | 1.06 |
| Inventory Turnover Ratio (X) | 8.58 | 8.48 | 6.77 | 4.34 | 3.97 |
| Interest Coverage Ratio (X) | -1.48 | 0.22 | 0.19 | 0.45 | 0.89 |
| Interest Coverage Ratio (Post Tax) (X) | -1.59 | 0.20 | 0.17 | 0.42 | 0.83 |
| Enterprise Value (Cr.) | 201.55 | 807.36 | 730.02 | 377.91 | 507.33 |
| EV / Net Operating Revenue (X) | 0.37 | 1.15 | 1.16 | 0.87 | 1.22 |
| EV / EBITDA (X) | -3.18 | 51.44 | 57.21 | 16.27 | 10.63 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| Price / BV (X) | 0.27 | -5.13 | -3.05 | -102.76 | 8.62 |
| Price / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| EarningsYield | 1.37 | -0.20 | -0.35 | -0.14 | -0.04 |
After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
- For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
- For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
- For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
- For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
- For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
- For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.58. This value exceeds the healthy maximum of 8. It has increased from 8.48 (Mar 24) to 8.58, marking an increase of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
- Net Profit Margin: 73.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.43% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.47% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 33.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 73.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | Ambalamugal PO, Ernakulam Kerala 682302 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogendra Prasad Shukla | Chairman & M.D & CFO |
| Mr. Subodh Kumar | Non Official Independent Director |
| Mr. Vinay Kumar Sharma | Non Official Independent Director |
| Mr. Manoj Sethi | Government Nominee Director |
| Ms. Vandana | Government Nominee Director |
FAQ
What is the intrinsic value of Hindustan Organic Chemicals Ltd?
Hindustan Organic Chemicals Ltd's intrinsic value (as of 12 February 2026) is ₹932.84 which is 2833.46% higher the current market price of ₹31.80, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹213 Cr. market cap, FY2025-2026 high/low of ₹45.0/22.4, reserves of ₹953 Cr, and liabilities of ₹1,539 Cr.
What is the Market Cap of Hindustan Organic Chemicals Ltd?
The Market Cap of Hindustan Organic Chemicals Ltd is 213 Cr..
What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 12 February 2026?
The current stock price of Hindustan Organic Chemicals Ltd as on 12 February 2026 is ₹31.8.
What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Organic Chemicals Ltd stocks is ₹45.0/22.4.
What is the Stock P/E of Hindustan Organic Chemicals Ltd?
The Stock P/E of Hindustan Organic Chemicals Ltd is .
What is the Book Value of Hindustan Organic Chemicals Ltd?
The Book Value of Hindustan Organic Chemicals Ltd is 152.
What is the Dividend Yield of Hindustan Organic Chemicals Ltd?
The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.
What is the ROCE of Hindustan Organic Chemicals Ltd?
The ROCE of Hindustan Organic Chemicals Ltd is 5.20 %.
What is the ROE of Hindustan Organic Chemicals Ltd?
The ROE of Hindustan Organic Chemicals Ltd is 21.6 %.
What is the Face Value of Hindustan Organic Chemicals Ltd?
The Face Value of Hindustan Organic Chemicals Ltd is 10.0.